483 Bristol-Myers Squibb Company Apr 2017

483 Bristol-Myers Squibb Company Apr 2017

Erik Koester FDA, Sean Marcsisin FDA, Robert Martin FDA, Erik Koester FDA, Sean Marcsisin FDA, Robert Martin FDA$119.00 - Available Now

FDA investigators audited the Bristol-Myers Squibb Company - Devens, MA, United States facility and issued inspectional observations (via FDA 483) on 05 Apr 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 05 Apr 2017
  • Location: Devens, United States
  • FEI: 3008455069
Add To Cart